available technology

Suppression of Allergic Asthma by Ascaris Antigens

Available for licensing and commercial development are compositions and methods for suppressing allergic reactions, as well as Th-1 and Th-2 associated immunological diseases, by administering any of the two identified Ascaris polypeptide antigens, or active fragments or variants thereof, to the...